← back to search

Zhe Liu

Boston College · US
Area of research
Infectious Diseases · Oncology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, SARS-CoV-2 and COVID-19 Research, Cancer Genomics and Diagnostics, and SARS-CoV-2 detection and testing.
h-index
23
citations
2,905
works
182
NIH funding
primary concept
email

Recent publications

Emission characteristics of VOCs from the typical spent lithium-ion battery recycling industry
Journal of Hazardous Materials 2025cited by 8position: middledoi
ADSC-derived exosomes mitigate radiation-induced skin injury by reducing oxidative stress, inflammation and cell death
Frontiers in Public Health 2025cited by 7position: firstdoi
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
The Lancet Respiratory Medicine 2025cited by 2position: middledoi
Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Nature Communications 2024cited by 14position: middledoi
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
The Lancet Respiratory Medicine 2024cited by 8position: middledoi
Evaluation of Tembusu virus single-round infectious particle as vaccine vector in chickens
Veterinary Microbiology 2024cited by 1position: middledoi
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
Nature Communications 2022cited by 472position: middledoi
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
ACS Nano 2021cited by 233position: middledoi
Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma
International Journal of Biological Sciences 2021cited by 74position: middledoi
Abstract CT170: D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156)
Cancer Research 2021cited by 1position: middledoi
Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
Journal of Virology 2020cited by 178position: firstdoi
The clinical utility of QSM: disease diagnosis, medical management, and surgical planning
NMR in Biomedicine 2016cited by 111position: middledoi
Early myocardial damage assessment in dystrophinopathies using 99Tcm-MIBI gated myocardial perfusion imaging
Therapeutics and Clinical Risk Management 2015cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Changwen Ke · National Kaohsiung University of Science and Technology2 papers (2020–2021)Jiufeng Sun · Sun Yat-sen University2 papers (2020–2024)Baisheng Li · Guangdong Provincial Center for Disease Control and Prevention2 papers (2020–2024)Lina Yi · Nanchang University2 papers (2020–2024)Jing Lu · Beijing University of Chinese Medicine2 papers (2020–2024)Jianfeng He · Polar Research Institute of China1 papers (2024–2024)Haiyi Yang · China University of Petroleum, Beijing1 papers (2024–2024)Ruben J. G. Hulswit · Utrecht University1 papers (2020–2020)Zhiwei Ji · University of Manchester1 papers (2021–2021)Zhen Zhuang · The First Affiliated Hospital of Guangzhou Medical University1 papers (2021–2021)Runyu Yuan · Southwest Jiaotong University1 papers (2020–2020)Mingda Yang · Jinan University1 papers (2024–2024)Guo‐Kai Feng · Sun Yat-sen University1 papers (2021–2021)Yin-Feng Kang · Sun Yat-sen University1 papers (2021–2021) · 1 papers (2015–2015)Qing‐Bao Tian · Hebei Medical University1 papers (2015–2015)Qingbing Zheng · Sun Yat-sen University Cancer Center1 papers (2021–2021)Sarah Eskreis‐Winkler · Memorial Sloan Kettering Cancer Center1 papers (2016–2016)Xiang‐Wei Kong · Sun Yat-sen University1 papers (2021–2021)Lei Zhou · Université Claude Bernard Lyon 11 papers (2025–2025)